{"id":42372,"date":"2026-03-23T11:04:30","date_gmt":"2026-03-23T14:04:30","guid":{"rendered":"https:\/\/www.grupomedcof.com.br\/blog\/?p=42372"},"modified":"2026-03-23T11:06:09","modified_gmt":"2026-03-23T14:06:09","slug":"guideline-dislipidemia-acc-aha","status":"publish","type":"post","link":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/","title":{"rendered":"O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026?"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_74 counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Sum\u00e1rio<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabela de conte\u00fado\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Predizendo_Risco_Cardiovascular\" >Predizendo Risco Cardiovascular<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Calculando_o_LDL-c\" >Calculando o LDL-c<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Retorno_das_Metas_Absolutas_de_LDL-C_e_Nao-HDL-C\" >Retorno das Metas Absolutas de LDL-C e N\u00e3o-HDL-C<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Biomarcadores_de_Precisao_Lpa_e_ApoB\" >Biomarcadores de Precis\u00e3o: Lp(a) e ApoB<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Estratificacao_por_Imagem_Escore_de_Calcio_e_Achados_Incidentais\" >Estratifica\u00e7\u00e3o por Imagem: Escore de C\u00e1lcio e Achados Incidentais<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Arsenal_Farmacologico_Terapias_Nao-Estatinas\" >Arsenal Farmacol\u00f3gico: Terapias N\u00e3o-Estatinas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Hipertrigliceridemia_e_IPE\" >Hipertrigliceridemia e IPE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Manejo_de_Populacoes_Especificas\" >Manejo de Popula\u00e7\u00f5es Espec\u00edficas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#Sintomas_Musculares_SAMS_O_Efeito_%E2%80%9CDrucebo%E2%80%9D\" >Sintomas Musculares (SAMS): O Efeito &#8220;Drucebo&#8221;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#O_caminho_definitivo_para_o_seu_RQE_comeca_aqui\" >O caminho definitivo para o seu RQE come\u00e7a aqui<\/a><\/li><\/ul><\/nav><\/div>\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1080\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg\" alt=\"\" class=\"wp-image-42375\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg 1920w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-300x169.jpg 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-1024x576.jpg 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-768x432.jpg 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-1536x864.jpg 1536w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-747x420.jpg 747w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-150x84.jpg 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-696x392.jpg 696w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15-1068x601.jpg 1068w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \/><\/figure>\n\n\n\n<p>A nova diretriz da <strong>American Heart Association (AHA)<\/strong> e do <strong>American College of Cardiology (ACC)<\/strong> de <strong>2026<\/strong> sobre o manejo da dislipidemia representa uma mudan\u00e7a de paradigma, aposentando documentos anteriores (2018) para focar na redu\u00e7\u00e3o da exposi\u00e7\u00e3o vital\u00edcia a lipoprote\u00ednas aterog\u00eanicas. A premissa central \u00e9 que o tratamento deve ser iniciado o mais cedo poss\u00edvel para mitigar o risco acumulado ao longo das d\u00e9cadas.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-predizendo-risco-cardiovascular\"><span class=\"ez-toc-section\" id=\"Predizendo_Risco_Cardiovascular\"><\/span><strong>Predizendo Risco Cardiovascular<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A diretriz substitui formalmente as antigas <em>Pooled Cohort Equations<\/em> (PCE) pelas equa\u00e7\u00f5es <strong>PREVENT&#x2122;<\/strong> (<em>Predicting Risk of cardiovascular disease EVENTs<\/em>) para adultos de <strong>30 a 79 anos<\/strong>. As novas equa\u00e7\u00f5es s\u00e3o consideradas mais precisas, pois foram derivadas de amostras contempor\u00e2neas, incluem a fun\u00e7\u00e3o renal (<strong>TFGe<\/strong>) e removem a ra\u00e7a como vari\u00e1vel preditora.<\/p>\n\n\n\n<p>A avalia\u00e7\u00e3o de risco agora segue o <strong>&#8220;CPR&#8221;<\/strong>:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Calculate (Calcular):<\/strong> Estimar o risco em 10 e 30 anos via PREVENT&#x2122;.<\/li>\n\n\n\n<li><strong>Personalize (Personalizar):<\/strong> Avaliar <strong>fatores potencializadores de risco (risk enhancers)<\/strong>, como hist\u00f3ria familiar, doen\u00e7as inflamat\u00f3rias cr\u00f4nicas e novos <strong>marcadores reprodutivos<\/strong> (menopausa precoce &lt;45 anos e complica\u00e7\u00f5es na gravidez).<\/li>\n\n\n\n<li><strong>Reclassify (Reclassificar):<\/strong> Usar o <strong>Escore de C\u00e1lcio Coron\u00e1rio (CAC)<\/strong> para refinar a decis\u00e3o quando houver incerteza cl\u00ednica.<\/li>\n<\/ol>\n\n\n\n<p>Os novos limiares de risco de 10 anos pelo PREVENT&#x2122; s\u00e3o ajustados, j\u00e1 que suas estimativas tendem a ser <strong>40% a 50% menores<\/strong> que as da PCE:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Baixo:<\/strong> &lt;3%.<\/li>\n\n\n\n<li><strong>Borderline:<\/strong> 3% a &lt;5%.<\/li>\n\n\n\n<li><strong>Intermedi\u00e1rio:<\/strong> 5% a &lt;10%.<\/li>\n\n\n\n<li><strong>Alto:<\/strong> &gt;=10%.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-calculando-o-ldl-c\"><span class=\"ez-toc-section\" id=\"Calculando_o_LDL-c\"><\/span><strong>Calculando o LDL-c<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Para a estimativa do LDL-c, a diretriz recomenda o abandono da cl\u00e1ssica Equa\u00e7\u00e3o de Friedewald, preferindo as equa\u00e7\u00f5es de <strong>Martin\/Hopkins<\/strong> ou <strong>Sampson\/NIH<\/strong>. Estas f\u00f3rmulas oferecem maior acur\u00e1cia, especialmente em pacientes com <strong>LDL &lt;70 mg\/dL<\/strong> ou <strong>triglicer\u00eddeos (TG) elevados<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-retorno-das-metas-absolutas-de-ldl-c-e-nao-hdl-c\"><span class=\"ez-toc-section\" id=\"Retorno_das_Metas_Absolutas_de_LDL-C_e_Nao-HDL-C\"><\/span><strong>Retorno das Metas Absolutas de LDL-C e N\u00e3o-HDL-C<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A diretriz de 2026 restabelece metas terap\u00eauticas claras para guiar a terapia lipo-redutora (LLT), refor\u00e7ando que a porcentagem de redu\u00e7\u00e3o e o valor absoluto atingido s\u00e3o ambos priorit\u00e1rios.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1016\" height=\"782\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-12.png\" alt=\"\" class=\"wp-image-42374\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-12.png 1016w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-12-300x231.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-12-768x591.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-12-546x420.png 546w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-12-150x115.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-12-696x536.png 696w\" sizes=\"auto, (max-width: 1016px) 100vw, 1016px\" \/><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Muito alto risco e\/ou Escore de C\u00e1lcio (CAC) &gt;= 1000 e\/ou DRC est\u00e1gios 3 ou 4:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Meta de LDL-c (mg\/dL): &lt;55<\/li>\n\n\n\n<li>Meta de N\u00e3o-HDL (mg\/dL): &lt;85<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Alto risco (&gt;=10% ou CAC &gt;= 300):<\/strong>\n<ul class=\"wp-block-list\">\n<li>Meta de LDL-c (mg\/dL): &lt;70<\/li>\n\n\n\n<li>Meta de N\u00e3o-HDL (mg\/dL): &lt;100<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Diabetes (40-75 anos, sem outros riscos):<\/strong>\n<ul class=\"wp-block-list\">\n<li>Meta de LDL-c (mg\/dL): &lt;100<\/li>\n\n\n\n<li>Meta de N\u00e3o-HDL (mg\/dL): &lt;130<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Diabetes (com m\u00faltiplos fatores de risco):<\/strong>\n<ul class=\"wp-block-list\">\n<li>Meta de LDL-c (mg\/dL): &lt;70<\/li>\n\n\n\n<li>Meta de N\u00e3o-HDL (mg\/dL): &lt;100<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"632\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-1024x632.png\" alt=\"\" class=\"wp-image-42373\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-1024x632.png 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-300x185.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-768x474.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-680x420.png 680w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-150x93.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-696x430.png 696w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11-1068x659.png 1068w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/image-11.png 1215w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-biomarcadores-de-precisao-lp-a-e-apob\"><span class=\"ez-toc-section\" id=\"Biomarcadores_de_Precisao_Lpa_e_ApoB\"><\/span><strong>Biomarcadores de Precis\u00e3o: Lp(a) e ApoB<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lipoprote\u00edna (a) [Lp(a)]:<\/strong> Deve ser medida <strong>pelo menos uma vez na vida<\/strong> em todos os adultos. N\u00edveis <strong>&gt;= 50 mg\/dL (125 nmol\/L)<\/strong> s\u00e3o fator potencializador de risco (aumento de 1,4x no risco), enquanto n\u00edveis <strong>&gt;= 100 mg\/dL (250 nmol\/L)<\/strong> dobram o risco cardiovascular.<\/li>\n\n\n\n<li><strong>Apolipoprote\u00edna B (ApoB):<\/strong> Recomendada para refinar a avalia\u00e7\u00e3o de risco residual em pacientes que j\u00e1 atingiram metas de LDL, mas possuem <strong>TG &gt;200 mg\/dL<\/strong>, diabetes, s\u00edndrome metab\u00f3lica ou LDL-C &lt;70 mg\/dL.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-estratificacao-por-imagem-escore-de-calcio-e-achados-incidentais\"><span class=\"ez-toc-section\" id=\"Estratificacao_por_Imagem_Escore_de_Calcio_e_Achados_Incidentais\"><\/span><strong>Estratifica\u00e7\u00e3o por Imagem: Escore de C\u00e1lcio e Achados Incidentais<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>O uso do CAC \u00e9 validado para homens &gt;= 40 anos e mulheres &gt;= 45 anos.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>CAC = 0:<\/strong> Pode-se adiar a estatina, exceto em diab\u00e9ticos, tabagistas ou hist\u00f3ria familiar forte de ASCVD prematura.<\/li>\n\n\n\n<li><strong>CAC &gt; 0:<\/strong> Indica\u00e7\u00e3o de in\u00edcio de terapia.<\/li>\n\n\n\n<li><strong>CAC &gt;= 100 ou percentil &gt;= 75:<\/strong> Recomenda\u00e7\u00e3o forte de LLT para meta de LDL &lt;70 mg\/dL.<\/li>\n\n\n\n<li><strong>CAC &gt;= 1000:<\/strong> Tratamento agressivo (meta LDL &lt;55).<\/li>\n\n\n\n<li><strong>CAC Incidental:<\/strong> Se calcifica\u00e7\u00e3o coron\u00e1ria for identificada em <strong>TCs n\u00e3o-card\u00edacas<\/strong> (como rastreio de c\u00e2ncer de pulm\u00e3o), a diretriz recomenda considerar o achado para iniciar ou intensificar a LLT.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-arsenal-farmacologico-terapias-nao-estatinas\"><span class=\"ez-toc-section\" id=\"Arsenal_Farmacologico_Terapias_Nao-Estatinas\"><\/span><strong>Arsenal Farmacol\u00f3gico: Terapias N\u00e3o-Estatinas<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Embora as <strong>estatinas<\/strong> permane\u00e7am como base, a terapia combinada \u00e9 sugerida para atingir metas rigorosas.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Ezetimiba:<\/strong> Primeira linha adicional para falha em atingir metas.<\/li>\n\n\n\n<li><strong>Inibidores da PCSK9 (mAbs):<\/strong> Recomendados precocemente para pacientes de muito alto risco ou com LDL &gt;= 190 mg\/dL persistente.<\/li>\n\n\n\n<li><strong>\u00c1cido Bemped\u00f3ico:<\/strong> Op\u00e7\u00e3o para intolerantes a estatinas ou necessidade de redu\u00e7\u00e3o adicional ao uso delas.<\/li>\n\n\n\n<li><strong>Inclisiran:<\/strong> Indicado como alternativa em pacientes com dificuldade de ades\u00e3o ou intoler\u00e2ncia aos anticorpos monoclonais, com ou sem tratamento com ezetimiba.<\/li>\n\n\n\n<li><strong>Lomitapide\/Evinacumab:<\/strong> Reservado para Hipercolesterolemia Familiar Homozig\u00f3tica (HoFH).<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-hipertrigliceridemia-e-ipe\"><span class=\"ez-toc-section\" id=\"Hipertrigliceridemia_e_IPE\"><\/span><strong>Hipertrigliceridemia e IPE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Para <strong>TG entre 150-499 mg\/dL<\/strong>, o foco \u00e9 estilo de vida e estatina. O uso de <strong>Icosapent Etil (IPE)<\/strong> \u00e9 recomendado em pacientes &gt;= 50 anos com ASCVD ou diabetes e fatores de risco que mant\u00eam TG elevado apesar da estatina. Para preven\u00e7\u00e3o de pancreatite em <strong>TG &gt;= 1000 mg\/dL<\/strong>, fibratos e \u00f4mega-3 s\u00e3o indicados, al\u00e9m do novo agente <strong>Olezarsen<\/strong> para s\u00edndrome de quilomicronemia familiar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-manejo-de-populacoes-especificas\"><span class=\"ez-toc-section\" id=\"Manejo_de_Populacoes_Especificas\"><\/span><strong>Manejo de Popula\u00e7\u00f5es Espec\u00edficas<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>HIV:<\/strong> Estatinas (preferencialmente <strong>pitavastatina<\/strong>) s\u00e3o indicadas para pacientes de 40-75 anos em terapia antirretroviral est\u00e1vel para prevenir o primeiro evento cardiovascular.<\/li>\n\n\n\n<li><strong>Doen\u00e7a Renal (DRC):<\/strong> Ezetimibe e estatinas de alta intensidade s\u00e3o recomendados para metas de <strong>LDL &lt;55<\/strong> em est\u00e1gios 3 e 4.<\/li>\n\n\n\n<li><strong>Idosos (&gt;75 anos):<\/strong> A decis\u00e3o de iniciar ou suspender deve ser individualizada, considerando funcionalidade e expectativa de vida. Se &lt; 1 ano de vida, pode-se descontinuar a LLT.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-sintomas-musculares-sams-o-efeito-drucebo\"><span class=\"ez-toc-section\" id=\"Sintomas_Musculares_SAMS_O_Efeito_%E2%80%9CDrucebo%E2%80%9D\"><\/span><strong>Sintomas Musculares (SAMS): O Efeito &#8220;Drucebo&#8221;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A diretriz destaca que muitos sintomas s\u00e3o subjetivos, de preval\u00eancia baixa, ou devidos ao efeito <strong>&#8220;drucebo&#8221;<\/strong> (expectativa negativa do paciente). Recomenda-se excluir causas secund\u00e1rias (hipotireoidismo, exerc\u00edcio vigoroso) antes da suspens\u00e3o definitiva e testar doses menores ou regimes alternativos (dias alternados) com estatinas de longa dura\u00e7\u00e3o antes de migrar totalmente para n\u00e3o-estatinas.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-o-caminho-definitivo-para-o-seu-rqe-comeca-aqui\"><span class=\"ez-toc-section\" id=\"O_caminho_definitivo_para_o_seu_RQE_comeca_aqui\"><\/span><strong>O caminho definitivo para o seu RQE come\u00e7a aqui<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/grupomedcof.com.br\/r\/blog-banner-guideline-aha\"><img loading=\"lazy\" decoding=\"async\" width=\"1600\" height=\"500\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27.png\" alt=\"tec 2026\" class=\"wp-image-42376\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27.png 1600w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-300x94.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-1024x320.png 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-768x240.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-1536x480.png 1536w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-1344x420.png 1344w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-150x47.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-696x218.png 696w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Banner-MedCof-Plus-2200x460-27-1068x334.png 1068w\" sizes=\"auto, (max-width: 1600px) 100vw, 1600px\" \/><\/a><\/figure>\n\n\n\n<p>Com uma metodologia ativa de aprendizado e aulas feitas por especialistas formados nas maiores institui\u00e7\u00f5es do pa\u00eds, condensamos todo o conte\u00fado necess\u00e1rio para dominar a prova da SBC em um s\u00f3 lugar.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/grupomedcof.com.br\/r\/blog-banner-guideline-aha\">Quero come\u00e7ar agora<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A nova diretriz ACC\/AHA 2026 de dislipidemias redefine o manejo da dislipidemia. Confira o que mudou na pr\u00e1tica cl\u00ednica.<\/p>\n","protected":false},"author":40,"featured_media":42375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[258,211,240],"tags":[154],"ppma_author":[3626],"class_list":{"0":"post-42372","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-atualizacoes","8":"category-cardiologia","9":"category-noticias","10":"tag-cardiologia"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.3 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026? - Blog de Medcof: conte\u00fados, editais, revalida e mais!<\/title>\n<meta name=\"description\" content=\"A nova diretriz ACC\/AHA 2026 de dislipidemias redefine o manejo da dislipidemia. Confira o que mudou na pr\u00e1tica cl\u00ednica.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026?\" \/>\n<meta property=\"og:description\" content=\"A nova diretriz ACC\/AHA 2026 de dislipidemias redefine o manejo da dislipidemia. Confira o que mudou na pr\u00e1tica cl\u00ednica.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog de Medcof: conte\u00fados, editais, revalida e mais!\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MedCofQbank\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-23T14:04:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-23T14:06:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Hideky Dolci\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hideky Dolci\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/\"},\"author\":{\"name\":\"Hideky Dolci\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/person\\\/b3e749a9f7144eb58c5f0d2b921a87c1\"},\"headline\":\"O que fala o novo Guideline de Dislipidemias da ACC\\\/AHA 2026?\",\"datePublished\":\"2026-03-23T14:04:30+00:00\",\"dateModified\":\"2026-03-23T14:06:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/\"},\"wordCount\":994,\"publisher\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Revalida-15.jpg\",\"keywords\":[\"Cardiologia\"],\"articleSection\":[\"Atualiza\u00e7\u00f5es\",\"Cardiologia\",\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/\",\"name\":\"O que fala o novo Guideline de Dislipidemias da ACC\\\/AHA 2026? - Blog de Medcof: conte\u00fados, editais, revalida e mais!\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Revalida-15.jpg\",\"datePublished\":\"2026-03-23T14:04:30+00:00\",\"dateModified\":\"2026-03-23T14:06:09+00:00\",\"description\":\"A nova diretriz ACC\\\/AHA 2026 de dislipidemias redefine o manejo da dislipidemia. Confira o que mudou na pr\u00e1tica cl\u00ednica.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Revalida-15.jpg\",\"contentUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Revalida-15.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/guideline-dislipidemia-acc-aha\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"O que fala o novo Guideline de Dislipidemias da ACC\\\/AHA 2026?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/\",\"name\":\"Blog de Medcof: conte\u00fados, editais, revalida e mais!\",\"description\":\"Acesso o blog de MedCof! Seu portal de conte\u00fados sobre resid\u00eancia m\u00e9dica, an\u00e1lise e editais e muito mais. Clique e confira!\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#organization\"},\"alternateName\":\"Blog de Medcof: conte\u00fados, editais, revalida e mais!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#organization\",\"name\":\"Grupo MedCof\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/logo-medcof.png\",\"contentUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/logo-medcof.png\",\"width\":768,\"height\":269,\"caption\":\"Grupo MedCof\"},\"image\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/MedCofQbank\\\/\",\"https:\\\/\\\/www.instagram.com\\\/grupomedcof\\\/\",\"https:\\\/\\\/br.linkedin.com\\\/company\\\/medcof\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCdHMuOHKICxcHwecxN8P-AA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/person\\\/b3e749a9f7144eb58c5f0d2b921a87c1\",\"name\":\"Hideky Dolci\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Hideky-96x96.pngfb55b5e1493a322d60ced0305d7296d8\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Hideky-96x96.png\",\"contentUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Hideky-96x96.png\",\"caption\":\"Hideky Dolci\"},\"description\":\"Sou estudante do 10\u00ba per\u00edodo de Medicina, criador de conte\u00fado e com fortes interesses em sa\u00fade acess\u00edvel, mas com abordagem cr\u00edtica e medicina baseada em evid\u00eancias. Estou sempre praticando algum esporte.\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/author\\\/hideky-dolci\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026? - Blog de Medcof: conte\u00fados, editais, revalida e mais!","description":"A nova diretriz ACC\/AHA 2026 de dislipidemias redefine o manejo da dislipidemia. Confira o que mudou na pr\u00e1tica cl\u00ednica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/","og_locale":"pt_BR","og_type":"article","og_title":"O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026?","og_description":"A nova diretriz ACC\/AHA 2026 de dislipidemias redefine o manejo da dislipidemia. Confira o que mudou na pr\u00e1tica cl\u00ednica.","og_url":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/","og_site_name":"Blog de Medcof: conte\u00fados, editais, revalida e mais!","article_publisher":"https:\/\/www.facebook.com\/MedCofQbank\/","article_published_time":"2026-03-23T14:04:30+00:00","article_modified_time":"2026-03-23T14:06:09+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg","type":"image\/jpeg"}],"author":"Hideky Dolci","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Hideky Dolci","Est. tempo de leitura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#article","isPartOf":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/"},"author":{"name":"Hideky Dolci","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/person\/b3e749a9f7144eb58c5f0d2b921a87c1"},"headline":"O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026?","datePublished":"2026-03-23T14:04:30+00:00","dateModified":"2026-03-23T14:06:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/"},"wordCount":994,"publisher":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#organization"},"image":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#primaryimage"},"thumbnailUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg","keywords":["Cardiologia"],"articleSection":["Atualiza\u00e7\u00f5es","Cardiologia","Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/","url":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/","name":"O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026? - Blog de Medcof: conte\u00fados, editais, revalida e mais!","isPartOf":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#primaryimage"},"image":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#primaryimage"},"thumbnailUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg","datePublished":"2026-03-23T14:04:30+00:00","dateModified":"2026-03-23T14:06:09+00:00","description":"A nova diretriz ACC\/AHA 2026 de dislipidemias redefine o manejo da dislipidemia. Confira o que mudou na pr\u00e1tica cl\u00ednica.","breadcrumb":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#primaryimage","url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg","contentUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/Revalida-15.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.grupomedcof.com.br\/blog\/guideline-dislipidemia-acc-aha\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.grupomedcof.com.br\/blog\/"},{"@type":"ListItem","position":2,"name":"O que fala o novo Guideline de Dislipidemias da ACC\/AHA 2026?"}]},{"@type":"WebSite","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#website","url":"https:\/\/www.grupomedcof.com.br\/blog\/","name":"Blog de Medcof: conte\u00fados, editais, revalida e mais!","description":"Acesso o blog de MedCof! Seu portal de conte\u00fados sobre resid\u00eancia m\u00e9dica, an\u00e1lise e editais e muito mais. Clique e confira!","publisher":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#organization"},"alternateName":"Blog de Medcof: conte\u00fados, editais, revalida e mais!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.grupomedcof.com.br\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#organization","name":"Grupo MedCof","url":"https:\/\/www.grupomedcof.com.br\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2022\/01\/logo-medcof.png","contentUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2022\/01\/logo-medcof.png","width":768,"height":269,"caption":"Grupo MedCof"},"image":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MedCofQbank\/","https:\/\/www.instagram.com\/grupomedcof\/","https:\/\/br.linkedin.com\/company\/medcof","https:\/\/www.youtube.com\/channel\/UCdHMuOHKICxcHwecxN8P-AA"]},{"@type":"Person","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/person\/b3e749a9f7144eb58c5f0d2b921a87c1","name":"Hideky Dolci","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/cropped-Hideky-96x96.pngfb55b5e1493a322d60ced0305d7296d8","url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/cropped-Hideky-96x96.png","contentUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/cropped-Hideky-96x96.png","caption":"Hideky Dolci"},"description":"Sou estudante do 10\u00ba per\u00edodo de Medicina, criador de conte\u00fado e com fortes interesses em sa\u00fade acess\u00edvel, mas com abordagem cr\u00edtica e medicina baseada em evid\u00eancias. Estou sempre praticando algum esporte.","url":"https:\/\/www.grupomedcof.com.br\/blog\/author\/hideky-dolci\/"}]}},"authors":[{"term_id":3626,"user_id":40,"is_guest":0,"slug":"hideky-dolci","display_name":"Hideky Dolci","avatar_url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2026\/03\/cropped-Hideky-96x96.png","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts\/42372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/users\/40"}],"replies":[{"embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/comments?post=42372"}],"version-history":[{"count":2,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts\/42372\/revisions"}],"predecessor-version":[{"id":42378,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts\/42372\/revisions\/42378"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/media\/42375"}],"wp:attachment":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/media?parent=42372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/categories?post=42372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/tags?post=42372"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/ppma_author?post=42372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}